+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Selective in vitro and in vivo binding of [(125)I]ADAM to serotonin transporters in rat brain



Selective in vitro and in vivo binding of [(125)I]ADAM to serotonin transporters in rat brain



Synapse 38(4): 403-412



An improved iodinated tracer, ADAM (2-((2-((dimethylamino)methyl)- phenyl)thio)-5-iodophenylamine) for imaging serotonin transporters (SERT) with single photon emission computerized tomography (SPECT), was prepared and characterized. Scatchard analysis of saturation binding of [(125)I]ADAM to rat frontal cortical membrane homogenates gave a K(d) value of 0.15 +/- 0.03 nM and a B(max) value of 194 +/- 65 fmol/mg protein. Biodistribution of [(125)I]ADAM in rat brain after an iv injection showed a high specific binding in the regions of hypothalamus, cortex, striatum, and hippocampus, where SERT are concentrated and the specific binding peaked at 120-240 min postinjection [(hypothalamus-cerebellum)/cerebellum = 4.3 at 120 min post-iv injection]. Moreover, the specific hypothalamic uptake was blocked by pretreatment with SERT selective competing drugs, such as paroxetine and (+)McN5652, while other noncompeting drugs, such as ketanserin, raclopride, and methylphenidate, showed no effect. The radioactive material recovered from rat brain homogenates at 120 min after [(125)I]ADAM injection showed primarily the original compound (>90%), a good indication of in vivo stability in the brain tissues. Both male and female rats showed similar and comparable organ distribution pattern and regional brain uptakes. Ex vivo autoradiograms of rat brain sections (120 min after iv injection of [(125)I]ADAM) showed intense labeling in several regions (olfactory tubercle, lateral septal nucleus, hypothalamic and thalamic nuclei, globus pallidus, central gray, superior colliculus, substantia nigra, interpeduncular nucleus, dorsal and median raphes, and locus coerulus), which parallel known SERT density. These results strongly suggest that the novel tracer ADAM is superior to the congers (i.e., IDAM) reported previously. When labeled with I-123, ADAM will be an improved and useful SPECT imaging agent for SERT in the brain.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 047327444

Download citation: RISBibTeXText

PMID: 11044887

DOI: 10.1002/1098-2396(20001215)38:4<403::aid-syn5>3.0.co;2-z


Related references

Selective in vitro and in vivo binding of (125I)ADAM to serotonin transporters in rat brain. Synapse (New York) 38(4): 403-412, 2000

123I labeled ADAM A selective novel radioligand for imaging of serotonin transporters in the human brain. Journal of Nuclear Medicine 43(5 Suppl.): 232P, 2002

Effects of increased endogenous serotonin on the in vivo binding of [11C]DASB to serotonin transporters in conscious monkey brain. Synapse 61(9): 724-731, 2007

Short term vs long term test–retest reproducibility ofI-ADAM for the binding of serotonin transporters in the human brain. 2011

Short term vs. long term test-retest reproducibility of ¹²³I-ADAM for the binding of serotonin transporters in the human brain. Psychiatry Research 194(3): 224-229, 2011

In vivo effect of antidepressants on [3H]paroxetine binding to serotonin transporters in rat brain. Neurochemical Research 33(11): 2250-2256, 2008

Effect of 1-(m-trifluoromethylphenyl)-piperazine on 3H-serotonin binding to membranes from rat brain in vitro and on serotonin turnover in rat brain in vivo. European Journal of Pharmacology 52(1): 11-16, 1978

In vivo quantification by SPECT of [123I] ADAM bound to serotonin transporters in the brains of rabbits. Nuclear Medicine and Biology 31(8): 995, 2004

In vivo serotonin transporter binding characteristics of selective serotonin reuptake inhibitors in mouse brain. Journal of Pharmacological Sciences 91(Suppl. I): 92P, 2003

Imaging serotonin transporters with 123I-ADAM brain SPECT in healthy non-human primates. Nuclear Medicine Communications 25(5): 515-519, 2004

123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. Journal of Nuclear Medicine 46(6): 973-977, 2005

Investigating the effects of noise-induced hearing loss on serotonin transporters in rat brain using 4-[18F]-ADAM/small animal PET. Neuroimage 75: 262-269, 2013

PET imaging of the brain serotonin transporters SERT with N,N-dimethyl-2-2-amino-4-18Ffluorophenylthiobenzylamine 4-18F-ADAM in humans a preliminary stud. 2013

PET imaging of the brain serotonin transporters SERT with N,N-dimethyl-2-2-amino-4-18Ffluorophenylthiobenzylamine 4-18F-ADAM in humans a preliminary study. 2012

PET imaging of the brain serotonin transporters (SERT) with N,N-dimethyl-2-(2-amino-4-[18F]fluorophenylthio)benzylamine (4-[18F]-ADAM) in humans: a preliminary study. European Journal of Nuclear Medicine and Molecular Imaging 40(1): 115-124, 2013